Health Education During Ramadan Fasting in Type 1 Diabetes

NCT03501511 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2018-06-29

No results posted yet for this study

Summary

Adult Muslims are obliged to start fasting during the month of Ramadan. Fasting entails refraining from all food, drink, tablets and injections(vitamins \& fluids) between sunrise and sunset; a period which varies by geographical location and season.

People with type 1 Diabetes are among those who are risky to fast this holy month in the Muslim faith and thus are exempted from fasting. Yet many patients fast in spite of medical advice and religious exemption and for those patients, healthcare professionals should provide the utmost care and continuous diabetes education.

Different diabetes education modalities exist like DSME (Diabetes self-management education with proven efficacy. One modality is the Diabetes Conversation Map which delivers diabetes education interactively through a series of maps that address different issues in diabetes management and includes a specially designed Ramadan map.

In this study, two modalities of Diabetes focused Ramadan education will be compared regarding aiding patients to fast Ramadan safely. One modality will be Diabetes conversation maps and the other the International Diabetes Federation Education modules.

Conditions

  • Diabetes Mellitus, Type 1
  • Fasting

Interventions

BEHAVIORAL

IDF modules

Patients in this arm will receive Pre-Ramadan education using IDF module for 4 weeks prior to Ramadan fasting

BEHAVIORAL

Conversational Maps

Patients in this arm will receive Pre-Ramadan Education using Ramadan Fasting Diabetes conversation map for 4 weeks prior to Ramadan fasting

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Yara M Eid, MD · Ain-Shams University -Faculty of Medicine

  • Manal A AbuShady, MD · Ain-Shams University -Faculty of Medicine

  • Mona M AbdelSalam, MD · Ain-Shams University -Faculty of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-07
Primary Completion
2018-06-28
Completion
2018-06-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03501511 on ClinicalTrials.gov